Skip to main content

TAK ALG-25 (Nesina 25 mg)

Generic Name: alogliptin

Pill with imprint TAK ALG-25 is Red, Elliptical/Oval and has been identified as Nesina 25 mg. It is supplied by Takeda Pharmaceuticals America, Inc.

Nesina is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Nesina 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TAK ALG-25

Nesina 25 mg TAK ALG-25

Nesina

Generic Name
alogliptin
Imprint
TAK ALG-25
Strength
25 mg
Color
Red
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Takeda Pharmaceuticals America, Inc.
Inactive Ingredients
mannitol, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), titanium dioxide, ferric oxide red, polyethylene glycol 8000, shellac, ferrosoferric oxide, butyl alcohol, alcohol

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
64764-0250 Takeda Pharmaceutical Company Limited
45802-0150 Perrigo Company

Get help with Imprint Code FAQs.

Related images for "TAK ALG-25"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.